HIT Consultant October 31, 2024
What You Should Know:
– Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus, a fund established in collaboration with the renowned MD Anderson Cancer Center.
– The investment will support Starget Pharma’s upcoming clinical trial for treating advanced metastatic cancers, including sarcomas, neuroendocrine tumors, melanoma, and liver cancer.
Revolutionizing Cancer Treatment with Targeted Radiotherapy
Starget Pharma, co-founded by CEO Sigal Clemenson-Kushnir and Chairman Ronen Clemenson, has raised a total of $15.1M to date. Starget Pharma, founded in 2019 through ARC Innovation, the innovation arm of Sheba Medical Center, is developing groundbreaking radioligand-based therapies. These therapies precisely target tumor cells with focused radiation, minimizing damage to...
Today's Sponsors
Today's Sponsor